Search

Your search keyword '"Nemoto H"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Nemoto H" Remove constraint Author: "Nemoto H" Journal anticancer research Remove constraint Journal: anticancer research
37 results on '"Nemoto H"'

Search Results

1. Hederagenin Glycoside Isolated from the Pericarps of Akebia quinata Fruits Induces Apoptotic Cell Death in Breast Cancer Cells.

2. Garlic ( Allium sativum L.) Organosulfur Compounds Inhibit Breast Cancer Cell Proliferation by Decreasing Steroid Sulfatase Levels.

3. FBN2 methylation is detected in the serum of colorectal cancer patients with hepatic metastasis.

4. Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancer.

5. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.

6. Detection of vimentin methylation in the serum of patients with gastric cancer.

7. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.

8. Detection of TFPI2 methylation in the serum of gastric cancer patients.

9. Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer.

10. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.

11. Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.

12. Aberrant methylation of the Vimentin gene in hepatocellular carcinoma.

13. Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.

14. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.

15. TIP60 as a potential marker for the malignancy of gastric cancer.

16. Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients.

17. Down-regulation of Mus81 as a potential marker for the malignancy of gastric cancer.

18. Methylation of the TFPI2 gene is frequently detected in advanced gastric carcinoma.

19. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma.

20. Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer.

21. MACC1 as a marker for advanced colorectal carcinoma.

22. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.

23. Demethylation of the CD133 gene is frequently detected in early gastric carcinoma.

24. Methylation of the DCC gene is lost in advanced gastric cancer.

25. Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma.

26. Changes in UNC5C gene methylation during human gastric carcinogenesis.

27. Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer.

28. Frequent CDH3 demethylation in advanced gastric carcinoma.

29. Methylation of HACE1 in gastric carcinoma.

30. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer.

31. Frequent methylation of Vimentin in well-differentiated gastric carcinoma.

32. Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer.

33. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.

34. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.

35. Vimentin methylation as a marker for advanced colorectal carcinoma.

36. PGP9.5 methylation as a marker for metastatic colorectal cancer.

37. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.

Catalog

Books, media, physical & digital resources